June 2020 Issue of Neurosurgical Focus: Pituitary Tumors
Charlottesville, VA (June 1, 2020). The June issue of Neurosurgical Focus (Vol. 48, No. 6 [thejns.org/toc/foc/48/6]) addresses the present and future status of the management of pituitary tumors.
Diagnostic and intraoperative imaging, results of genomic and molecular biology investigations into tumor pathogenesis, surgical techniques, and machine learning analysis to predict patient outcomes are just some of the topics covered.
Here is a list of articles in the June issue:
“Introduction. Management of pituitary tumors: 2020 and beyond” by Gabriel Zada et al.
“Optimizing pre-, intra-, and postoperative management of patients with sellar pathology undergoing transsphenoidal surgery” by David J. Cote et al.
“Does pituitary compression/empty sella syndrome contribute to MRI-negative Cushing’s disease? A single-institution experience” by Benjamin T. Himes et al.
“Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing’s disease” by Michael D. Cusimano et al.
“Machine learning–based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming?” by Matteo Zoli et al.
“Editorial. Machine learning and artificial intelligence applied to the diagnosis and management of Cushing disease” by Edward R. Laws Jr. and Michael P. Catalino
“Surgical outcomes and multidisciplinary management strategy of Cushing’s disease: a single-center experience in China” by Keyi Zhang et al.
“PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly” by Waiel A. Bashari et al.
“Real-life analysis of 280 patients with surgically treated acromegaly: a single-center experience from 2008 to 2015” by Roman Rotermund et al.
“Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly” by Tyler Cardinal et al.
“Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities” by Mazin Elsarrag et al.
“Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings” by João Vitor Gerdulli Tamanini et al.
“Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of pituitary adenomas from a single institution” by Alexander F. Haddad et al.
“Ten years’ experience with intraoperative MRI-assisted transsphenoidal pituitary surgery” by Michal Hlaváč et al.
”Assessing the surgical outcome of the ‘chopsticks’ technique in endoscopic transsphenoidal adenoma surgery” by Carlo Serra et al.
“Repair of the sellar floor using bioresorbable polydioxanone foils after endoscopic endonasal pituitary surgery” by Jan-Philip Zeden et al.
“Prior smoking and nasoseptal flap usage adversely impact quality of life and healing after endoscopic pituitary surgery” by Aryan Shay et al.
Join us in reading this issue of Neurosurgical Focus and keep up with management of pituitary tumors.
Neurosurgical Focus, an online-only, monthly, peer-reviewed journal, covers a different neurosurgery-related topic in depth each month and is available free to all readers at http://www.thejns.org. Enhanced by color images and video clips, each issue constitutes a state-of-the-art "textbook chapter" in the field of neurosurgery. Neurosurgical Focus is one of five journals published by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons. Other peer-reviewed journals published by the JNS Publishing Group each month include the Journal of Neurosurgery, the Journal of Neurosurgery: Spine, the Journal of Neurosurgery: Pediatrics, and Neurosurgical Focus: Video. All five journals can be accessed at www.thejns.org.
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 10,000 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the entire nervous system including the brain, spinal column, spinal cord, and peripheral nerves. For more information, visit www.AANS.org.